An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling.

Cunha-Neto, Edecio; Rosa, Daniela S; Harris, Paul E; Olson, Tim; Morrow, Alex; Ciotlos, Serban; Herst, Charles V; Rubsamen, Reid Martin

Cunha-Neto, Edecio; Rosa, Daniela S; Harris, Paul E; Olson, Tim; Morrow, Alex; Ciotlos, Serban; Herst, Charles V; Rubsamen, Reid Martin.

Afiliação

Cunha-Neto E; Laboratory of Clinical Immunology and Allergy-LIM60, University of São Paulo School of Medicine, São Paulo, Brazil.
Rosa DS; Institute for Investigation in Immunology (III) INCT, São Paulo, Brazil.
Harris PE; School of Medicine, Heart Institute (Incor), University of São Paulo, São Paulo, Brazil.
Olson T; Institute for Investigation in Immunology (III) INCT, São Paulo, Brazil.
Morrow A; Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo (UNIFESP/EPM), São Paulo, Brazil.
Ciotlos S; Endocrinology Division, Department of Medicine, School of Medicine, Columbia University, New York, NY, United States.
Herst CV; Flow Pharma, Inc., Redwood City, CA, United States.
Rubsamen RM; Flow Pharma, Inc., Redwood City, CA, United States.

Front Immunol ; 8: 640, 2017.

Article em En | MEDLINE | ID: mdl-28649242

Palavras-chave

CTL vaccine; Zika vaccine; computer model; dengue; epitope; flavivirus; protein folding

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Brasil

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google